Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poupart

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Cancers|February 25, 2023
Addictions, Social Deprivation and Cessation Failure in Head and Neck Squamous Cell Carcinoma SurvivorsLara Nokovitch, Yonjae Kim, Philippe Zrounba, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 14, 2024
Current and future burden from Lyme disease in Québec as a result of climate changeMarion Ripoche, Alexandra Irace-Cima, Ariane Adam-Poupart, et al.
Plos One|August 23, 2018
Evidence for increasing densities and geographic ranges of tick species of public health significance other than Ixodes scapularis in Québec, CanadaSalima Gasmi, Catherine Bouchard, Nicholas H Ogden, et al.
Psychology and Psychotherapy|October 5, 2019
Does the Beck Cognitive Insight Scale predict change in delusional beliefs?Louise Penzenstadler, Anne Chatton, Tania Lecomte, et al.
Nature Communications|November 20, 2025
High average-flux laser-driven neutron sourceSimon Vallières, François Fillion-Gourdeau, Sylvain Fourmaux, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivativesPierre L Beaulieu, Michael Bös, Yves Bousquet, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitorsM Llinàs-Brunet, M Bailey, G Fazal, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine proteaseM Llinàs-Brunet, M Bailey, R Déziel, et al.
Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2004
Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective studyC De Champs, C Chanal, D Sirot, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Cancers|February 25, 2023
Addictions, Social Deprivation and Cessation Failure in Head and Neck Squamous Cell Carcinoma SurvivorsLara Nokovitch, Yonjae Kim, Philippe Zrounba, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 14, 2024
Current and future burden from Lyme disease in Québec as a result of climate changeMarion Ripoche, Alexandra Irace-Cima, Ariane Adam-Poupart, et al.
Plos One|August 23, 2018
Evidence for increasing densities and geographic ranges of tick species of public health significance other than Ixodes scapularis in Québec, CanadaSalima Gasmi, Catherine Bouchard, Nicholas H Ogden, et al.
Psychology and Psychotherapy|October 5, 2019
Does the Beck Cognitive Insight Scale predict change in delusional beliefs?Louise Penzenstadler, Anne Chatton, Tania Lecomte, et al.
Nature Communications|November 20, 2025
High average-flux laser-driven neutron sourceSimon Vallières, François Fillion-Gourdeau, Sylvain Fourmaux, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivativesPierre L Beaulieu, Michael Bös, Yves Bousquet, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitorsM Llinàs-Brunet, M Bailey, G Fazal, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine proteaseM Llinàs-Brunet, M Bailey, R Déziel, et al.
Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2004
Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective studyC De Champs, C Chanal, D Sirot, et al.
Pageof 20